These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 913025

  • 1. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM, Birkett DJ, Wade DN.
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of phenylbutazone elimination by its metabolite oxyphenbutazone.
    Jähnchen E, Levy G.
    Proc Soc Exp Biol Med; 1972 Dec; 141(3):963-5. PubMed ID: 4645785
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.
    Tobin T, Blake JW, Valentine R.
    Am J Vet Res; 1977 Jan; 38(1):123-7. PubMed ID: 835859
    [Abstract] [Full Text] [Related]

  • 7. Interaction of phenylbutazone and tolbutamide in man.
    Szita M, Gachályi B, Tornyossy M, Káldor A.
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):378-80. PubMed ID: 7450929
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
    Spahn H, Mutschler E, Geissler HE, Faust-Tinnefeldt G.
    Arzneimittelforschung; 1981 Sep; 31(3):499-503. PubMed ID: 6894380
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of tolbutamide 4-methylhydroxylation by a series of non-steroidal anti-inflammatory drugs in V79-NH cells expressing human cytochrome P4502C10.
    Kappers WA, Groene EM, Kleij LA, Witkamp RF, Zweers-Zeilmaker WM, Feron VJ, Horbach GJ.
    Xenobiotica; 1996 Dec; 26(12):1231-9. PubMed ID: 9004453
    [Abstract] [Full Text] [Related]

  • 10. Studies of the interaction of phenylbutazone, oxyphenbutazone and methandrostenolone in man.
    Hvidberg EF, Dayton PG, Read JM, Wilson CH.
    Proc Soc Exp Biol Med; 1968 Nov; 129(2):438-43. PubMed ID: 5696765
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Interactions of phenylbutazone and oxyphenbutazone with glymidine (author's transl)].
    Held M, Scheible G.
    Arzneimittelforschung; 1981 Nov; 31(6):1036-8. PubMed ID: 6455124
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of DNA synthesis in cultured human lymphocytes by phenylbutazone and oxyphenbutazone.
    Dewse CD.
    J Pharm Pharmacol; 1976 Jul; 28(7):596-8. PubMed ID: 8620
    [No Abstract] [Full Text] [Related]

  • 18. Displacement of tolbutamide, glibencalmide and chlorpropamide from serum albumin by anionic drugs.
    Brown KF, Crooks MJ.
    Biochem Pharmacol; 1976 May 15; 25(10):1175-8. PubMed ID: 820348
    [No Abstract] [Full Text] [Related]

  • 19. [A contribution on the antiproteolytic activity quality of phenylbutazone, oxyphenbutazone and sodium salicylate].
    Mörsdorf K, Marten S, Puchert I.
    Arzneimittelforschung; 1968 Dec 15; 18(12):1516-20. PubMed ID: 5756244
    [No Abstract] [Full Text] [Related]

  • 20. Effects of phenylbutazone and oxyphenbutazone on acidic drug detection in high performance thin layer chromatographic systems.
    Woods WE, Weckman T, Blake JW, Tobin T.
    J Pharmacol Methods; 1986 Dec 15; 16(4):297-313. PubMed ID: 3784574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.